Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement -- GLENWOOD, Ill., July 24, 2012 /PRNewswire/ --
Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
GLENWOOD, Ill., July 24, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: [ LDR ]), a recognized leader in personal and environmental radiation monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Peter Cempellin to President of Landauer's Radiation Measurement segment effective immediately.
"Pete's previous professional experiences will make him a great addition to Landauer. His involvement with a very dynamic business in positron emission tomography (PET/CT) coupled with his leadership in delivering the first ever commercially viable, FDA approved Time-OF-Flight PET/CT System, is quite impressive. This was a market changing disruptive technology that changed the imaging landscape," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc.
In this role, Mr. Cempellin will direct and lead the strategic and operating direction for the Dosimetry Products and Services Business. He will have responsibility for the firm's manufacturing operations, technical laboratory services and international channel partners within the corporation's radiation measurement business segment.
Prior to Landauer, Mr. Cempellin served as President and CEO of CAE Healthcare Inc., a provider of simulation training products including surgical, patient, and ultrasound imaging simulators addressing the educational needs of surgeons, gastroenterologists, cardiologists and intensivists.
Before joining CAE Healthcare, Mr. Cempellin held a variety of executive management positions including Vice President and General Manager at Analogic Corporation, a manufacturer of diagnostic computed tomography (CT) systems and image guided radiation therapy systems (IG-IMRT) and also served as General Manager of Philips Healthcare's Nuclear Medicine Business including PET/CT and molecular imaging systems. Under Mr. Cempellin, Philips Healthcare created the world's first Time-of-Flight PET/CT system, a breakthrough in medical imaging diagnostics and also initiated the world's first whole body PET/MR imaging system.
"Landauer is a world leader in radiation science and services, and I am delighted to join such a dynamic, innovative company," said Mr. Cempellin. "Given the company's strong position in occupational and patient radiation monitoring and services, I believe there are extraordinary opportunities to grow and build shareholder value. I look forward to working closely with Landauer employees, as well as customers, shareholders and business partners."
Mr. Cempellin earned a Master in Business Administration from Boston University School of Management and a Bachelor of Science in Mechanical Engineering from Northeastern University.
"Pete's marketing capabilities and keen business sense will drive continued product development and market expansion for our Radiation Measurement business segment. His global customer and operations experience will be a key component to Landauer's growth strategy," said Saxelby. "We are excited to welcome Pete to our team."
About Landauer
Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.7 million individuals globally. In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community. Through its IZI Medical Products subsidiary, the Company provides medical consumable accessories used in radiology, radiation therapy, and image guided surgery procedures.
SOURCE Landauer, Inc.
[ Back to top ]
RELATED LINKS
[ http://www.landauerinc.com ]